Literature DB >> 26998252

Self-Assembled Nanospheres for Encapsulation and Aerosolization of Rifampicin.

Aline A Ishikawa1, Jesus V Salazar2, Magaly Salinas3, Cristiane M Gaitani4, Timothy Nurkiewicz5, George R Negrete3, Carlos D Garcia6.   

Abstract

Rifampicin (RIF) is a benchmark drug for treatment of tuberculosis, but poor bioavailability, prolonged treatment, and pill burden have been linked to therapeutic failure and the development of multidrug resistant strains. To overcome these limitations, this study investigated a method of rifampicin nanoencapsulation and aerosol delivery using a commercial, hand-held nebulizer modified with a nitrogen stream.

Entities:  

Year:  2016        PMID： 26998252      PMCID： PMC4792303          DOI： 10.1039/C5RA25044G

Source DB:  PubMed          Journal:  RSC Adv        ISSN： 2046-2069            Impact factor:   3.361


  18 in total

1.  Solid-state characterization of rifampicin samples and its biopharmaceutic relevance.

Authors:  Shrutidevi Agrawal; Yasvanth Ashokraj; Prasad V Bharatam; Omathanu Pillai; Ramesh Panchagnula
Journal:  Eur J Pharm Sci       Date:  2004-06       Impact factor: 4.384

2.  Effervescent dry powder for respiratory drug delivery.

Authors:  Leticia Ely; Wilson Roa; Warren H Finlay; Raimar Löbenberg
Journal:  Eur J Pharm Biopharm       Date:  2006-11-07       Impact factor: 5.571

Review 3.  Development of nanoparticles for antimicrobial drug delivery.

Authors:  L Zhang; D Pornpattananangku; C-M J Hu; C-M Huang
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

Review 4.  Liposomes as delivery systems for antibiotics.

Authors:  Zuzanna Drulis-Kawa; Agata Dorotkiewicz-Jach
Journal:  Int J Pharm       Date:  2009-12-05       Impact factor: 5.875

5.  In vitro controlled release of Rifampicin through liquid-crystalline folate nanoparticles.

Authors:  Rohan Parmar; Rahul Misra; Sanat Mohanty
Journal:  Colloids Surf B Biointerfaces       Date:  2015-03-31       Impact factor: 5.268

6.  Production of Inhalable Submicrometer Aerosols from Conventional Mesh Nebulizers for Improved Respiratory Drug Delivery.

Authors:  P Worth Longest; Benjamin M Spence; Landon T Holbrook; Karla M Mossi; Yoen-Ju Son; Michael Hindle
Journal:  J Aerosol Sci       Date:  2012-04-14       Impact factor: 3.433

7.  Delivery of rifampicin-chitin nanoparticles into the intracellular compartment of polymorphonuclear leukocytes.

Authors:  K T Smitha; N Nisha; S Maya; Raja Biswas; R Jayakumar
Journal:  Int J Biol Macromol       Date:  2014-12-02       Impact factor: 6.953

8.  Acid-responsive nanospheres from an asparagine-derived amphiphile.

Authors:  Adelphe M Mfuh; Mathew P D Mahindaratne; Audrey E Yñigez-Gutierrez; Juan R Ramos Dominguez; Jefferson T Bedell; Carlos D Garcia; George R Negrete
Journal:  RSC Adv       Date:  2015       Impact factor: 3.361

Review 9.  Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis.

Authors:  Mandeep Kaur; Tarun Garg; Goutam Rath; Amit Kumar Goyal
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2014       Impact factor: 4.889

10.  Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung.

Authors:  Jeffrey O-H Sham; Yu Zhang; Warren H Finlay; Wilson H Roa; Raimar Löbenberg
Journal:  Int J Pharm       Date:  2004-01-28       Impact factor: 5.875
View more
  2 in total

1.  Confinement Effects on Chemical Equilibria: Pentacyano(Pyrazine)Ferrate(II) Stability Changes within Nanosized Droplets of Water.

Authors:  Teofilo Borunda; Alexander J Myers; J Mary Fisher; Debbie C Crans; Michael D Johnson
Journal:  Molecules       Date:  2018-04-09       Impact factor: 4.411

Review 2.  Nano-based anti-tubercular drug delivery: an emerging paradigm for improved therapeutic intervention.

Authors:  Bushra Nabi; Saleha Rehman; Sumit Aggarwal; Sanjula Baboota; Javed Ali
Journal:  Drug Deliv Transl Res       Date:  2020-08       Impact factor: 5.671
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.